{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T12:15:03Z","timestamp":1782908103820,"version":"3.54.5"},"reference-count":52,"publisher":"Wiley","license":[{"start":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T00:00:00Z","timestamp":1626480000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Innovative Team Plan of the Second Affiliated Hospital of Shaanxi University of Chinese Medicine","award":["2020XKTD-A04"],"award-info":[{"award-number":["2020XKTD-A04"]}]},{"name":"Innovative Team Plan of the Second Affiliated Hospital of Shaanxi University of Chinese Medicine","award":["2019-QN02"],"award-info":[{"award-number":["2019-QN02"]}]},{"name":"Subject Innovation Team of Shaanxi University of Chinese Medicine","award":["2020XKTD-A04"],"award-info":[{"award-number":["2020XKTD-A04"]}]},{"name":"Subject Innovation Team of Shaanxi University of Chinese Medicine","award":["2019-QN02"],"award-info":[{"award-number":["2019-QN02"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Evidence-Based Complementary and Alternative Medicine"],"published-print":{"date-parts":[[2021,7,17]]},"abstract":"<jats:p>Introduction. Coronary heart disease (CHD) is a common clinical cardiovascular disease, and its morbidity and mortality rates are increasing, which brings a serious burden to the family and society. Dyslipidemia is one of the most important risk factors for CHD. However, it is difficult to reduce blood lipids to an ideal state with the administration of a statin alone. Tongxinluo capsule (TXLC), as a Chinese patent medicine, has received extensive attention in the treatment of CHD in recent years. This systematic review and meta-analysis aim to provide evidence-based medicine for TXLC combined with atorvastatin in the treatment of CHD. Objective. To evaluate systematically the effectiveness and safety of TXLC combined with atorvastatin in the treatment of CHD. Methods. Seven English and Chinese electronic databases (PubMed, Cochrane Library, Embase, CNKI, VIP, CBM, and Wanfang) were searched from inception to January 2020, to search for randomized controlled trials (RCTs) on TXLC combined with atorvastatin in the treatment of CHD. Two researchers independently screened the literature according to the literature inclusion and exclusion criteria and performed quality assessment and data extraction on the included RCTs. We performed a systematic review following Cochrane Collaboration Handbook and Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and using a measurement tool to assess the methodological quality of systematic reviews (AMSTAR 2). The quality of outcomes was evaluated by the Grading of Recommendations Assessment, Development and Evaluation (GRADE). And meta-analysis was performed by Review Manager 5.2. Results. A total of 15 RCTs with 1,578 participants were included in this review. Compared to atorvastatin treatment, TXLC combined with atorvastatin treatment showed potent efficacy when it came to the effectiveness of clinical treatment (RR\u2009=\u20091.24; 95% CI, 1.18, 1.29; <jats:inline-formula>\n                     <a:math xmlns:a=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M1\">\n                        <a:mi>P<\/a:mi>\n                        <a:mo>&lt;<\/a:mo>\n                        <a:mn>0.00001<\/a:mn>\n                     <\/a:math>\n                  <\/jats:inline-formula>), total cholesterol (TC; MD\u2009=\u2009\u22121.21; 95% CI, \u22121.53, \u22120.89; <jats:inline-formula>\n                     <c:math xmlns:c=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M2\">\n                        <c:mi>P<\/c:mi>\n                        <c:mo>&lt;<\/c:mo>\n                        <c:mn>0.00001<\/c:mn>\n                     <\/c:math>\n                  <\/jats:inline-formula>), triacylglycerol (TG; MD\u2009=\u2009\u22120.73; 95% CI, \u22120.81, \u22120.65; <jats:inline-formula>\n                     <e:math xmlns:e=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M3\">\n                        <e:mi>P<\/e:mi>\n                        <e:mo>&lt;<\/e:mo>\n                        <e:mn>0.00001<\/e:mn>\n                     <\/e:math>\n                  <\/jats:inline-formula>), high-density lipoprotein cholesterol (HDL-C; MD\u2009=\u20090.27; 95% CI, 0.23, 0.31; <jats:inline-formula>\n                     <g:math xmlns:g=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M4\">\n                        <g:mi>P<\/g:mi>\n                        <g:mo>&lt;<\/g:mo>\n                        <g:mn>0.00001<\/g:mn>\n                     <\/g:math>\n                  <\/jats:inline-formula>), low-density lipoprotein cholesterol (LDL-C; MD\u2009=\u2009\u20130.72; 95% CI, \u20130.80, \u22120.64; <jats:inline-formula>\n                     <i:math xmlns:i=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M5\">\n                        <i:mi>P<\/i:mi>\n                        <i:mo>&lt;<\/i:mo>\n                        <i:mn>0.00001<\/i:mn>\n                     <\/i:math>\n                  <\/jats:inline-formula>), C-reactive protein (CRP; SMD\u2009=\u2009\u22122.06; 95% CI, \u22122.56, \u22121.57; <jats:inline-formula>\n                     <k:math xmlns:k=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M6\">\n                        <k:mi>P<\/k:mi>\n                        <k:mo>&lt;<\/k:mo>\n                        <k:mn>0.00001<\/k:mn>\n                     <\/k:math>\n                  <\/jats:inline-formula>), frequency of angina pectoris (SMD\u2009=\u2009\u22121.41; 95% CI, \u22121.97, \u22120.85; <jats:inline-formula>\n                     <m:math xmlns:m=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M7\">\n                        <m:mi>P<\/m:mi>\n                        <m:mo>&lt;<\/m:mo>\n                        <m:mn>0.00001<\/m:mn>\n                     <\/m:math>\n                  <\/jats:inline-formula>), duration of angina pectoris (MD\u2009=\u2009\u22122.30; 95% CI, \u22123.39, \u22121.21; <jats:inline-formula>\n                     <o:math xmlns:o=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M8\">\n                        <o:mi>P<\/o:mi>\n                        <o:mo>&lt;<\/o:mo>\n                        <o:mn>0.0001<\/o:mn>\n                     <\/o:math>\n                  <\/jats:inline-formula>), and adverse reactions (RR\u2009=\u20090.84; 95% CI, 0.51, 1.39; <jats:inline-formula>\n                     <q:math xmlns:q=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M9\">\n                        <q:mi>P<\/q:mi>\n                        <q:mo>=<\/q:mo>\n                        <q:mn>0.50<\/q:mn>\n                     <\/q:math>\n                  <\/jats:inline-formula>). No serious adverse events or reactions were mentioned in these RCTs. According to the PRISMA guidelines, although all studies were not fully reported in accordance with the checklist item, the reported items exceeded 80% of all items. With the AMSTAR 2 standard, the methodological quality assessment found that 9 studies were rated low quality and 6 studies were rated critically low quality. Based on the results of the systematic review, the GRADE system recommended ranking method was used to evaluate the quality of evidence and the recommendation level. The results showed that the level of evidence was low, and the recommendation intensity was a weak recommendation. Conclusions. TXLC combined with atorvastatin in the treatment of CHD can effectively improve the effectiveness of clinical treatment, significantly reduce the frequency and duration of angina pectoris, decrease blood lipids, and improve inflammatory factors. However, due to the low quality of the literature included in these studies and the variability of the evaluation methods of each study, there is still a need for a more high-quality, large sample, multicenter clinical randomized control for further demonstration.<\/jats:p>","DOI":"10.1155\/2021\/9413704","type":"journal-article","created":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T20:05:10Z","timestamp":1626725110000},"page":"1-17","source":"Crossref","is-referenced-by-count":5,"title":["Tongxinluo Capsule Combined with Atorvastatin for Coronary Heart Disease: A Systematic Review and Meta-Analysis"],"prefix":"10.1155","volume":"2021","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1956-6891","authenticated-orcid":true,"given":"Qiao","family":"Liu","sequence":"first","affiliation":[{"name":"Shaanxi University of Chinese Medicine, Xianyang 712046, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiwei","family":"Dong","sequence":"additional","affiliation":[{"name":"Shaanxi University of Chinese Medicine, Xianyang 712046, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4367-2056","authenticated-orcid":true,"given":"Miaomiao","family":"Xi","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Licheng","family":"Gou","sequence":"additional","affiliation":[{"name":"Shaanxi Provincial Hospital of Traditional Chinese Medicine, Xi\u2019an 710000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Bai","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Hou","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[{"name":"Shaanxi University of Chinese Medicine, Xianyang 712046, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8767-1322","authenticated-orcid":true,"given":"Li","family":"Ou","sequence":"additional","affiliation":[{"name":"Shaanxi University of Chinese Medicine, Xianyang 712046, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2863-3489","authenticated-orcid":true,"given":"Feng","family":"Miao","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8652-5312","authenticated-orcid":true,"given":"Peifeng","family":"Wei","sequence":"additional","affiliation":[{"name":"Shaanxi University of Chinese Medicine, Xianyang 712046, China"},{"name":"The Second Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"issue":"7","key":"1","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1253\/circj.CJ-15-0520","article-title":"Structural and functional coronary artery abnormalities in patients with vasospastic angina pectoris","volume":"79","author":"P. Ong","year":"2015","journal-title":"Circulation Journal"},{"issue":"23","key":"2","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1136\/heartjnl-2016-311097","article-title":"Persistent psychological distress and mortality in patients with stable coronary artery disease","volume":"103","author":"R. A. H. Stewart","year":"2017","journal-title":"Heart"},{"key":"3","volume-title":"Practical Internal Medicine","author":"H. Z. Chen","year":"2009"},{"issue":"4","key":"4","first-page":"266","article-title":"Evaluation of the therapeutic effect and clinical safety of atorvastatin calcium combined with ezetimibe on coronary heart disease","volume":"35","author":"R. Li","year":"2016","journal-title":"Journal of Cardiopulmonary and Vascular Disease"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1006\/exmp.2000.2339"},{"key":"6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1177\/0003319712451115","article-title":"Assessment of low-density lipoprotein targets","volume":"64","author":"T. F. Whayne","year":"2013","journal-title":"Angiology"},{"issue":"23","key":"7","first-page":"113","article-title":"Explore the effect and clinical safety of atorvastatin calcium combined with new ezetimibe drugs in the treatment of coronary heart disease","volume":"26","author":"T. T. Liu","year":"2018","journal-title":"Chinese Medicine Guide"},{"issue":"31","key":"8","first-page":"3473","article-title":"Analysis of therapeutic effect of Xintong oral liquid on unstable Angina pectoris of coronary heart disease","volume":"24","author":"Y. Y. Zhang","year":"2015","journal-title":"Modern Journal of Integrated Traditional Chinese and Western Medicine"},{"key":"9","first-page":"2395","article-title":"C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapy","volume-title":"Circulation","author":"R. Puri"},{"issue":"1","key":"10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1253\/circj.CJ-13-0783","article-title":"Echolucency of carotid plaque is useful for assessment of residual cardiovascular risk in patients with chronic coronary artery disease who achieve LDL-C goals on statin therapy","volume":"78","author":"M. Uematsu","year":"2013","journal-title":"Circ J"},{"issue":"1","key":"11","first-page":"8","article-title":"Study on the correlation of blood stasis syndrome and its concurrent syndrome with coronary angiography and restenosis after intervention","volume":"27","author":"H. Xu","year":"2007","journal-title":"Chinese Journal of Integrated Traditional Chinese and Western Medicine"},{"issue":"3","key":"12","first-page":"134","article-title":"Protective effects of Chinese medicine compatibility of promoting blood circulation and detoxification on adapted myocardial tissues of rats","volume":"17","author":"L. Zhang","year":"2010","journal-title":"Chinese Journal of Integrated Traditional Chinese and Western Medicine Emergency"},{"issue":"21","key":"13","first-page":"68","article-title":"Study on the value of Tongxinluo capsule in the clinical treatment of coronary heart disease and angina pectoris","volume":"6","author":"Y. H. Sun","year":"2018","journal-title":"Integrated Traditional Chinese and Western Medicine Cardiovascular Disease"},{"issue":"5","key":"14","first-page":"267","article-title":"Clinical study on the effect of Tongxinluo capsule on unstable plaque of cervical atherosclerosis","volume":"6","author":"X. S. Huang","year":"2007","journal-title":"Journal of Intractable Diseases"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6949348"},{"key":"16","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"D. Moher","year":"2009","journal-title":"Journal of Clinical Epidemiology"},{"key":"17","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"B. J. Shea","year":"2017","journal-title":"BMJ"},{"issue":"15","key":"18","first-page":"1765","article-title":"Effect of atorvastatin combined with Tongxinluo capsule on cTnI, HbA1c and clinical efficacy in patients with coronary heart disease","volume":"14","author":"L. Hang","year":"2016","journal-title":"Journal of Cardiovascular and Cerebral Vascular Diseases"},{"issue":"5","key":"19","first-page":"3","article-title":"Clinical observation of atorvastatin combined with Tongxinluo capsule in the treatment of unstable angina pectoris due to coronary heart disease","volume":"9","author":"S. G. Liu","year":"2016","journal-title":"Journal of Clinical Rational Use"},{"issue":"11","key":"20","first-page":"2003","article-title":"Clinical efficacy and safety analysis of atorvastatin combined with Tongxinluo capsule in the treatment of coronary heart disease","volume":"28","author":"Y. L. Qiao","year":"2017","journal-title":"Modern Diagnosis and Treatment"},{"issue":"17","key":"21","first-page":"49+52","article-title":"Effectiveness and safety of Tongxinluo capsule combined with atorvastatin on angina pectoris of coronary heart disease","volume":"6","author":"L. Z. Song","year":"2018","journal-title":"Electronic Journal of Integrated Traditional Chinese and Western Medicine for Cardiovascular Diseases"},{"issue":"7","key":"22","first-page":"107","article-title":"Effect of Tongxinluo capsule and atorvastatin calcium on patients with coronary heart disease and unstable angina pectoris","volume":"16","author":"F. P. Nie","year":"2018","journal-title":"Journal of Contemporary Medicine"},{"issue":"23","key":"23","first-page":"4263","article-title":"Effect of Tongxinluo capsule combined with atorvastatin calcium on coronary heart disease unstable angina pectoris","volume":"26","author":"H. X. Li","year":"2017","journal-title":"Henan Medical Research"},{"issue":"4","key":"24","first-page":"58","article-title":"Clinical effect analysis of Tongxinluo capsule combined with atorvastatin in the treatment of coronary heart disease and angina pectoris","volume":"26","author":"L. B. Yuan","year":"2018","journal-title":"Clinical Research"},{"issue":"8","key":"25","first-page":"96","article-title":"Clinical observation of Tongxinluo capsule combined with atorvastatin in the treatment of coronary heart disease and angina pectoris","volume":"24","author":"S. Y. Zhao","year":"2016","journal-title":"Journal of Practical Cardiocerebral Pulmonary Vascular Disease"},{"issue":"35","key":"26","first-page":"19","article-title":"Clinical effect of Tongxinluo combined with atorvastatin on unstable angina pectoris due to coronary heart disease and its effect on high-sensitivity C-reactive protein","volume":"12","author":"J. Qian","year":"2014","journal-title":"Chinese and Foreign Medical Research"},{"issue":"8","key":"27","first-page":"141","article-title":"Effect of Tongxinluo combined with atorvastatin on coronary heart disease unstable angina pectoris and its effect on high-sensitivity C-reactive protein","volume":"14","author":"L. P. Qiao","year":"2017","journal-title":"Northern Medicine"},{"issue":"17","key":"28","first-page":"57","article-title":"Effect of Tongxinluo combined with atorvastatin on coronary heart disease unstable angina pectoris and its effect on high-sensitivity C-reactive protein","volume":"13","author":"H. Y. Jiang","year":"2019","journal-title":"China Modern Drug Application"},{"issue":"17","key":"29","first-page":"124","article-title":"Clinical effect of Tongxinluo combined with atorvastatin on unstable angina pectoris due to coronary heart disease","volume":"25","author":"J. L. Wu","year":"2017","journal-title":"Chinese Contemporary Medicine"},{"issue":"2","key":"30","first-page":"98","article-title":"Effect of Tongxinluo and Atorvastatin on unstable angina pectoris due to coronary heart disease","volume":"4","author":"E. Z. Wang","year":"2018","journal-title":"Smart Health"},{"issue":"6","key":"31","first-page":"59","article-title":"Clinical effect of atorvastatin and Tongxinluo capsules on coronary heart disease","volume":"4","author":"Y. M. Song","year":"2012","journal-title":"Clinical Research in Traditional Chinese Medicine"},{"issue":"16","key":"32","first-page":"171","article-title":"Efficacy of atorvastatin combined with Tongxinluo capsule in the treatment of coronary heart disease","volume":"7","author":"X. H. Zeng","year":"2012","journal-title":"China Practical Medicine"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.328.7454.1490"},{"issue":"4","key":"34","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"Grade guidelines: 1. Introduction-grade evidence summary table and result summary table","volume":"64","author":"G. W. Group","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"35","first-page":"507","article-title":"Relationship between different types of coronary heart disease and TCM pathogenesis","volume":"15","author":"M. H. Sun","year":"2017","journal-title":"Journal of Integrated Traditional Chinese and Western Medicine Cardio-Cerebrovascular Disease"},{"key":"36","first-page":"3227","article-title":"Study on the mechanism of wendan decoction in treating coronary heart disease based on internet pharmacology","volume-title":"Chinese Pharmacy","author":"J. Y. Wu"},{"issue":"15","key":"37","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.115.016442","article-title":"Coronary collateral growth induced by physical exercise: results of the leipzig exercise training versus MEdica management in patients with stable coronary artery (EXCITE) trial","volume":"133","author":"S. M\u00f6bius-Winkler","year":"2016","journal-title":"Circulation"},{"issue":"5","key":"38","first-page":"68","article-title":"Comparative evaluation of the impact of four-week therapy with amlodipine and atenolol on quality of life andblood lipid composition in patients with coronary heart disease associated with metabolic syndrome","volume":"85","author":"V. V. Kalyuzhin","year":"2013","journal-title":"Ter Arkh"},{"issue":"6","key":"39","first-page":"636","article-title":"Effect of Tongxinluo capsule on angiogenesis function of myocardial ischemia rats","volume":"36","author":"B. R. Zhang","year":"2015","journal-title":"Journal of Taishan Medical College"},{"issue":"8","key":"40","first-page":"29","article-title":"Tongxinluo capsule for acute coronary syndrome and its effect on high sensitive C-reactive protein","volume":"34","author":"J. Y. Luo","year":"2015","journal-title":"Inner Mongolia Chinese Medicine"},{"issue":"13","key":"41","first-page":"31","article-title":"Clinical observation of Tongxinluo capsule in treating diabetic cardiomyopathy","volume":"35","author":"S. Zhao","year":"2015","journal-title":"New World of Diabetes"},{"issue":"12","key":"42","first-page":"1020","article-title":"Tongxinluo's alleviation of diabetic myocardial ischemia-reperfusion injury is related to its improvement of endothelial barrier function","volume":"29","author":"K. Qi","year":"2014","journal-title":"China Circulation Magazine"},{"issue":"1","key":"43","first-page":"93","article-title":"Analysis of the effect of rosuvastatin combined with Tongxinluo on inflammatory factors and carotid atherosclerosis","volume":"21","author":"Q. X. Xue","year":"2015","journal-title":"Modern Instruments and Medical"},{"issue":"8","key":"44","first-page":"1288","article-title":"Effects of Tongxinluo combined with trimetazidine on high-sensitivity C-reactive protein and blood lipids in patients with angina pectoris after PCI surgery","volume":"20","author":"H. L. Jia","year":"2012","journal-title":"Journal of Practical Cardiocerebral Pulmonary Vascular Disease"},{"issue":"35","key":"45","first-page":"5","article-title":"Clinical observation of Tongxinluo and atorvastatin in patients with unstable angina pectoris","volume":"3","author":"L. Sun","year":"2015","journal-title":"Chinese Journal of Cardiovascular Diseases"},{"issue":"6","key":"46","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1258\/vasc.2011.oa0306","article-title":"Statin treatment is associated with reduced toll-like receptor 4 immunohistochemical expression on carotid atherosclerotic plaques: a novel effect of statins","volume":"19","author":"A. Katsargyris","year":"2011","journal-title":"Vascular"},{"issue":"6","key":"47","first-page":"641","article-title":"Clinical observation on Tongxinluo capsule combined with atorvastatin in treating 36 cases of angina pectoris due to coronary heart disease","volume":"9","author":"L. Yang","year":"2014","journal-title":"Internal Medicine"},{"issue":"5","key":"48","first-page":"467","article-title":"Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy","volume":"15","author":"Q. Zhou","year":"2009","journal-title":"Cua Pharm Des"},{"issue":"2","key":"49","first-page":"242","article-title":"Progress in treatment of unstable angina pectoris of coronary heart disease with traditional Chinese medicine","volume":"34","author":"Y. B. Zhou","year":"2014","journal-title":"Henan Chinese Medicine"},{"key":"50","volume-title":"Clinical Study of Atorvastatin Calcium Combined with Tongxinluo Capsule on Patients with Unstable Angina Pectoris","author":"J. J. Li","year":"2014"},{"issue":"3","key":"51","first-page":"139","article-title":"The efficacy of Tongxinluo combined with atorvastatin in the treatment of unstable angina pectoris of coronary heart disease and its influence on high-sensitivity C-reactive protein","volume":"31","author":"Y. X. Gao","year":"2014","journal-title":"Traditional Chinese Medicine Information"},{"issue":"9748","key":"52","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0140-6736(10)61879-X","article-title":"CONSORT 2010 comments","volume":"376","author":"K. F. Schulz","year":"2010","journal-title":"Lancet"}],"container-title":["Evidence-Based Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/ecam\/2021\/9413704.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/ecam\/2021\/9413704.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/ecam\/2021\/9413704.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T20:06:11Z","timestamp":1626725171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/ecam\/2021\/9413704\/"}},"subtitle":[],"editor":[{"given":"Im Hee","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,7,17]]},"references-count":52,"alternative-id":["9413704","9413704"],"URL":"https:\/\/doi.org\/10.1155\/2021\/9413704","relation":{},"ISSN":["1741-4288","1741-427X"],"issn-type":[{"value":"1741-4288","type":"electronic"},{"value":"1741-427X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,17]]}}}